Citations (141)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Abdullah K Dolu, Ahmet Korkmaz, Harun Kundi & Umit Guray. (2020) Whole Blood Viscosity Predicts Nondipping Circadian Pattern in Essential Hypertension. Biomarkers in Medicine 14:14, pages 1-10.
Read now
Read now
Yiling Meng, Lei Bian, Meichao Zhang, Fang Bo, Xiao Lu & Dong Li. (2020) Liquid Biopsy and Their Application Progress in Head and Neck Cancer: Focus on Biomarkers Ctcs, Cfdna, Ctdna and Evs. Biomarkers in Medicine 14:14, pages 1393-1404.
Read now
Read now
Elisabetta Cavalcanti, Antonia Ignazzi, Francesco De Michele & Maria Lucia Caruso. (2019) PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors. Cancer Biology & Therapy 20:4, pages 423-430.
Read now
Read now
Anne Nobels, Karen Geboes & Gilbert M. D. Lemmens. (2016) May depressed and anxious patients with carcinoid syndrome benefit from treatment with selective serotonin reuptake inhibitors (SSRIs)?: findings from a case report. Acta Oncologica 55:11, pages 1370-1372.
Read now
Read now
Amir Mehrvarz Sarshekeh, Daniel M Halperin & Arvind Dasari. (2016) Update on Management of Midgut Neuroendocrine Tumors. International Journal of Endocrine Oncology 3:2, pages 175-189.
Read now
Read now
Lichun Sun, Qingqing Qian, Guangchun Sun, L. Vienna Mackey, Joseph A. Fuselier, David H. Coy & Cui-Yun Yu. (2016) Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide–drug conjugate via activating somatostatin receptor type II. Journal of Drug Targeting 24:2, pages 169-177.
Read now
Read now
Wieneke Alexandra Buikhuisen, Margot Elisabeth Theresia Tesselaar, Marie-Louise Francijntje van Velthuysen, Catharina Maria Korse, Babs Gilda Taal & Paul Baas. (2014) Neuroendocrine Tumors of the Lung: A Comprehensive Overview. International Journal of Endocrine Oncology 1:1, pages 71-79.
Read now
Read now
Parul Benien & Archana Swami. (2014) 3D Tumor Models: History, Advances and Future Perspectives. Future Oncology 10:7, pages 1311-1327.
Read now
Read now
Jiaxi Wu & Shane Starr. (2014) Low-Fidelity Compensatory Backup Alternative DNA Repair Pathways May Unify Current Carcinogenesis Theories. Future Oncology 10:7, pages 1239-1253.
Read now
Read now
Lichun Sun, Lynsie M. Morris, Jing Luo, L. Vienna Mackey, Juliana S. Leslie, Laura G. Franko-Tobin, Joseph A. Fuselier, Keith T. LePage & David H. Coy. (2011) Application of human pancreatic carcinoid BON cells for receptor-targeted drug development. Journal of Drug Targeting 19:8, pages 666-674.
Read now
Read now
Kjell E Öberg. (2011) Management of neuroendocrine tumors: current and future therapies. Expert Review of Endocrinology & Metabolism 6:1, pages 49-62.
Read now
Read now
Andrea Frilling, Frank Weber, Vito Cicinnati & Christoph Broelsch. (2007) Role of radiolabeled octreotide therapy in patients with metastatic neuroendocrine neoplasms. Expert Review of Endocrinology & Metabolism 2:4, pages 517-527.
Read now
Read now
Articles from other publishers (129)
Sabin Kshattry, Mary White, Jeremy Tchack, William Laskin & Pamela L. Kunz. (2023) A 46-Year-Old Woman With Chronic Dyspnea and Diarrhea. Chest 163:1, pages e23-e29.
Crossref
Crossref
Evan Vosburgh. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
10
.
Nagarjun Subash, Mishel Maria Papali, Khatri Prashant Bahadur, Chaithanya Avanthika, Sharan Jhaveri, Srijani Thannir, Meet Joshi & Sai Sudha Valisekka. (2022) Recent Advances in the Diagnosis and Management of Carcinoid Syndrome. Disease-a-Month 68:7, pages 101304.
Crossref
Crossref
Dominique Clement, Raj Srirajaskanthan & Martyn E. Caplin. 2022. Oxford Textbook of Endocrinology and Diabetes 3e. Oxford Textbook of Endocrinology and Diabetes 3e
971
977
.
Lisa Guccione, Karla Gough, Allison Drosdowsky, Timothy Price, Nick Pavlakis, David Wyld, David Ransom, Michael Michael & Penelope Schofield. (2022) The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis. Patient Education and Counseling 105:1, pages 212-220.
Crossref
Crossref
Levent Kabasakal, Emre Demirci & Nalan Alan Selçuk. 2022. Radionuclide Therapy. Radionuclide Therapy
173
186
.
Karim Alavi & Marylise Boutros. 2022. The ASCRS Textbook of Colon and Rectal Surgery. The ASCRS Textbook of Colon and Rectal Surgery
587
604
.
Aman Chauhan, Satya Das, Rachel Miller, Laura Luque, Samuel N. Cheuvront, James Cloud, Zach Tarter, Fariha Siddiqui, Robert A. Ramirez & Lowell Anthony. (2021) Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients?. BMC Cancer 21:1.
Crossref
Crossref
Andrea Goldmann & Thomas Clerici. 2021. Endocrine Surgery Comprehensive Board Exam Guide. Endocrine Surgery Comprehensive Board Exam Guide
711
745
.
Klaas Pieter Koopmans & A. H. Brouwers. 2021. PET and SPECT in Neurology. PET and SPECT in Neurology
1083
1093
.
Ulrika Jahn, Ezgi Ilan, Mattias Sandström, Ulrike Garske-Román, Mark Lubberink & Anders Sundin. (2020) <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy: Dose Response in Small Intestinal Neuroendocrine Tumors. Neuroendocrinology 110:7-8, pages 662-670.
Crossref
Crossref
Aura D. Herrera-Martínez, Richard A. Feelders, Rosanna Van den Dungen, Fadime Dogan-Oruc, Peter M. van Koetsveld, Justo P. Castaño, Wouter W. de Herder & Leo J. Hofland. (2020) Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells. Neuroendocrinology 110:5, pages 351-363.
Crossref
Crossref
Lisa Guccione, Karla Gough, Allison Drosdowsky, Krista Fisher, Timothy Price, Nick Pavlakis, Mustafa Khasraw, David Wyld, David Ransom, Grace Kong, Megan Rogers, Simone Leyden, John Leyden, Michael Michael & Penelope Schofield. (2019) Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention. JMIR Research Protocols 8:12, pages e14361.
Crossref
Crossref
Iveta Štibrániová, Pavlína Bartíková, Viera Holíková & Mária Kazimírová. (2019) Deciphering Biological Processes at the Tick-Host Interface Opens New Strategies for Treatment of Human Diseases. Frontiers in Physiology 10.
Crossref
Crossref
Michael Gock, Christina S Mullins, Christine Harnack, Friedrich Prall, Robert Ramer, Anja Göder, Oliver H Krämer, Ernst Klar & Michael Linnebacher. (2018) Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line. World Journal of Gastroenterology 24:33, pages 3749-3759.
Crossref
Crossref
Emre Demirci, Levent Kabasakal, Turkay Toklu, Meltem Ocak, Onur E. Şahin, Nalan Alan-Selcuk & Ahmet Araman. (2018) 177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours. Nuclear Medicine Communications 39:8, pages 789-796.
Crossref
Crossref
Nicholas Manguso, Alexandra Gangi, Jeffrey Johnson, Attiya Harit, Nicholas Nissen, Laith Jamil, Simon Lo, Ashley Wachsman, Andrew Hendifar & Farin Amersi. (2017) The role of pre‐operative imaging and double balloon enteroscopy in the surgical management of small bowel neuroendocrine tumors: Is it necessary?. Journal of Surgical Oncology 117:2, pages 207-212.
Crossref
Crossref
Krista Noonan, Jules Derks, Janessa Laskin & Anne-Marie C. Dingemans. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology
555
568.e6
.
Diana D. Shi, David P. Yuppa, Trevor Dutton, Lauren K. Brais, Sarah L. Minden, Ilana M. Braun, Matthew H. Kulke, Jennifer A. Chan & Fremonta L. Meyer. (2017) Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome. Cancer 123:14, pages 2735-2742.
Crossref
Crossref
James C. YaoKatherine A. GuthrieCesar MoranJonathan R. StrosbergMatthew H. KulkeJennifer A. ChanNoelle LoConteRobert R. McWilliamsEdward M. WolinBassam MattarShannon McDonoughHelen ChenCharles D. BlankeHoward S. Hochster. (2017) Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518. Journal of Clinical Oncology 35:15, pages 1695-1703.
Crossref
Crossref
Evan Vosburgh. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine
1
12
.
Esther Una Cidon. (2017) New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future. World Journal of Gastrointestinal Oncology 9:1, pages 4.
Crossref
Crossref
Vladimir Neychev & Electron Kebebew. (2017) Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature. International Journal of Surgical Oncology 2017, pages 1-14.
Crossref
Crossref
Rory L. Smoot, Saboor Khan & David M. Nagorney. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
1355
1367.e4
.
C. Mosquera, N.J. Koutlas & T.L. Fitzgerald. (2016) Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance. European Journal of Surgical Oncology (EJSO) 42:10, pages 1471-1477.
Crossref
Crossref
Fady Hannah-Shmouni, Constantine A. Stratakis & Christian A. Koch. (2016) Flushing in (neuro)endocrinology. Reviews in Endocrine and Metabolic Disorders 17:3, pages 373-380.
Crossref
Crossref
Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Olga Martínez-Sáez & Enrique Grande. (2016) Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors. The Oncologist 21:6, pages 701-707.
Crossref
Crossref
Simron Singh, Sylvia L. Asa, Chris Dey, Hagen Kennecke, David Laidley, Calvin Law, Timothy Asmis, David Chan, Shereen Ezzat, Rachel Goodwin, Ozgur Mete, Janice Pasieka, Juan Rivera, Ralph Wong, Eva Segelov & Daniel Rayson. (2016) Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus. Cancer Treatment Reviews 47, pages 32-45.
Crossref
Crossref
Tine Gregersen, Christina Brock, Anne-Mette Haase, Søren Laurberg, Asbjørn M Drewes, Henning Grønbæk & Klaus Krogh. (2016) Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea. Journal of Neurogastroenterology and Motility 22:2, pages 264-271.
Crossref
Crossref
Maja Cigrovski Berković, Tamara Čačev, Tina Catela Ivković, Jasminka Marout, Monika Ulamec, Vanja Zjačić-Rotkvić & Sanja Kapitanović. (2016) High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Molecular and Cellular Endocrinology 425, pages 61-68.
Crossref
Crossref
Heather L. Gelhorn, Matthew H. Kulke, Thomas O’Dorisio, Qi M. Yang, Jessica Jackson, Shanna Jackson, Kristi A. Boehm, Linda Law, Jacqueline Kostelec, Priscilla Auguste & Pablo Lapuerta. (2016) Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach. Clinical Therapeutics 38:4, pages 759-768.
Crossref
Crossref
K. Bouledrak, T. Walter, P.J. Souquet & C. Lombard-Bohas. (2016) Les carcinoïdes bronchiques métastatiques. Revue de Pneumologie Clinique 72:1, pages 41-48.
Crossref
Crossref
Sujata Narayanan & Pamela L. Kunz. (2016) Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors. Hematology/Oncology Clinics of North America 30:1, pages 163-177.
Crossref
Crossref
Anand Yuvaraj, Georgi Abraham, Abraham Kurien, Priyanka Koshy, Sanjeev Nair & Sudhakshina Ghosh. (2015) A maintenance hemodialysis diabetic patient with unexplained pulmonary and gastrointestinal involvement. Hemodialysis International 20:1.
Crossref
Crossref
Alexandria T Phan, Daniel M Halperin, Jennifer A Chan, David R Fogelman, Kenneth R Hess, Paige Malinowski, Eileen Regan, Chaan S Ng, James C Yao & Matthew H Kulke. (2015) Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. The Lancet Oncology 16:6, pages 695-703.
Crossref
Crossref
A. Brobeil, T. Dreyer, R. Schäffer, A. Bräuninger & S. Gattenlöhner. (2015) Neuroendokrine epitheliale Tumoren des oberen RespirationstraktsEpithelial neuroendocrine tumors of the upper respiratory tract. Der Pathologe 36:3, pages 271-277.
Crossref
Crossref
Rosa M. Sánchez, Ana María Wägner & Susan M. Webb. 2015. PanVascular Medicine. PanVascular Medicine
4653
4658
.
Vladimir Neychev & Electron Kebebew. 2015. Surgical Endocrinopathies. Surgical Endocrinopathies
333
340
.
Christopher N. Scipione & Mark S. Cohen. 2015. Surgical Oncology. Surgical Oncology
585
602
.
T P Wyche, A Dammalapati, H Cho, A D Harrison, G S Kwon, H Chen, T S Bugni & R Jaskula-Sztul. (2014) Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo. Cancer Gene Therapy 21:12, pages 518-525.
Crossref
Crossref
Nikhil Bhagat & Jean-Francois Geschwind. 2014. Urgent Interventional Therapies. Urgent Interventional Therapies
403
409
.
Yoon Suk Jung, Kyung Eun Yun, Yoosoo Chang, Seungho Ryu, Jung Ho Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim & Dong Il Park. (2014) Risk Factors Associated with Rectal Neuroendocrine Tumors: A Cross-Sectional Study. Cancer Epidemiology, Biomarkers & Prevention 23:7, pages 1406-1413.
Crossref
Crossref
Klaas Pieter Koopmans & Adrienne H. Brouwers. 2014. PET and SPECT in Neurology. PET and SPECT in Neurology
911
920
.
Cindy England Owen & Jeffrey P. Callen. 2013. Dermatologic Principles and Practice in Oncology. Dermatologic Principles and Practice in Oncology
75
85
.
Reese W. Randle, Scott A. Northrup, S. Joseph Sirintrapun, Douglas S. Lyles & John H. StewartIVIV. (2013) Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors. Surgery 154:6, pages 1323-1330.
Crossref
Crossref
M. Krausch, A. Raffel, M. Anlauf, M. Schott, N. Lehwald, A. Krieg, F. Kröpil, K. Cupisti & W. T. Knoefel. (2013) Secondary malignancy in patients with sporadic neuroendocrine neoplasia. Endocrine 44:2, pages 510-516.
Crossref
Crossref
Gabriel Rodrigues, Raghunath Prabhu & Bharadwaj Ravi. (2013) Small bowel carcinoid: a rare cause of bowel obstruction. BMJ Case Reports, pages bcr2013200875.
Crossref
Crossref
William I. Fisher, Aimee K. Johnson, Gary R. Elkins, Julie L. Otte, Debra S. Burns, Menggang Yu & Janet S. Carpenter. (2013) Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA: A Cancer Journal for Clinicians 63:3, pages 167-192.
Crossref
Crossref
Efren Martinez-Quintana, Maria Del Mar Avila-Gonzalez, Laura Suarez-Castellano & Fayna Rodriguez-Gonzalez. (2013) Metastatic Carcinoid Tumor Presenting As Right Sided Heart Failure. International Journal of Endocrinology and Metabolism 11:2.
Crossref
Crossref
Nikhil Bhagat, Diane K. Reyes, Mingde Lin, Ihab Kamel, Timothy M. Pawlik, Constantine Frangakis & J. F. Geschwind. (2012) Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury. CardioVascular and Interventional Radiology 36:2, pages 449-459.
Crossref
Crossref
Aparna Balachandran, Eric P. Tamm, Priya R. Bhosale, Madhavi Patnana, Raghu Vikram, Jason B. Fleming, Matthew H. Katz & Chuslip Charnsangavej. (2012) Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdominal Imaging 38:2, pages 342-357.
Crossref
Crossref
Rosa M. Sánchez, Ana M. Wägner & Susan M. Webb. 2013. PanVascular Medicine. PanVascular Medicine
1
8
.
K.E. Öberg. (2012) The Management of Neuroendocrine Tumours: Current and Future Medical Therapy Options. Clinical Oncology 24:4, pages 282-293.
Crossref
Crossref
Mei Dong, Alexandria T. Phan & James C. Yao. (2012) New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy. Clinical Cancer Research 18:7, pages 1830-1836.
Crossref
Crossref
Pallav GuptaShubhra SinghKamlesh YadavaNiraj Kumari. (2012) Typical carcinoid arising in mature teratoma of anterior mediastinum. Asian Cardiovascular and Thoracic Annals 20:1, pages 80-82.
Crossref
Crossref
Aparna Balachandran, Jason B. Fleming, Glenda G. Callender, Sunil Krishnan & James C. Yao. 2012. Oncologic Imaging: A Multidisciplinary Approach. Oncologic Imaging: A Multidisciplinary Approach
193
209
.
Saboor Khan, David M. Nagorney & Florencia G. Que. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
1305
1318.e3
.
M. D. Miljković, M. Girotra, R. R. Abraham & R. B. Erlich. (2011) Novel Medical Therapies of Recurrent and Metastatic Gastroenteropancreatic Neuroendocrine Tumors. Digestive Diseases and Sciences 57:1, pages 9-18.
Crossref
Crossref
Ginger J. Gardner, Diane Reidy-Lagunes & Paola A. Gehrig. (2011) Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecologic Oncology 122:1, pages 190-198.
Crossref
Crossref
Shantanu K. Gaur, Jeremy L. Friese, Cheryl A. Sadow, Rajasekhara Ayyagari, Christoph A. Binkert, Matthew P. Schenker, Matthew Kulke & Richard Baum. (2011) Hepatic Arterial Chemoembolization Using Drug-Eluting Beads in Gastrointestinal Neuroendocrine Tumor Metastatic to the Liver. CardioVascular and Interventional Radiology 34:3, pages 566-572.
Crossref
Crossref
Chaan S. NgChuslip CharnsangavejWei WeiJames C. Yao. (2011) Perfusion CT Findings in Patients With Metastatic Carcinoid Tumors Undergoing Bevacizumab and Interferon Therapy. American Journal of Roentgenology 196:3, pages 569-576.
Crossref
Crossref
Adamantios M. Mellis, Daniel C. Parker, David D. Buethe & Gennady Slobodov. (2011) Primary Carcinoid Tumor of the Ileal Efferent Limb of an Ileovesicostomy: A Case Report. Case Reports in Urology 2011, pages 1-3.
Crossref
Crossref
John A. Jakob, Carlo Mario Contreras, Eddie K. Abdalla, Alexandria Phan & James C. Yao. 2011. Gastrointestinal Oncology. Gastrointestinal Oncology
301
324
.
Daria Zorzi, Yuky Hayashi & Jean-Nicolas Vauthey. 2011. Venous Embolization of the Liver. Venous Embolization of the Liver
201
215
.
Manal M. Hassan & James C. Yao. 2011. Neuroendocrine Tumors. Neuroendocrine Tumors
1
10
.
Shinya Iida, Yasuhiro Miki, Katsuhiko Ono, Jun‐ichi Akahira, Takashi Suzuki, Kazuyuki Ishida, Mika Watanabe & Hironobu Sasano. (2010) Novel classification based on immunohistochemistry combined with hierarchical clustering analysis in non‐functioning neuroendocrine tumor patients. Cancer Science 101:10, pages 2278-2285.
Crossref
Crossref
K.E. Öberg. (2010) Gastrointestinal neuroendocrine tumors. Annals of Oncology 21, pages vii72-vii80.
Crossref
Crossref
Alexandria T. Phan, Kjell Öberg, Junsung Choi, Lynn H. Harrison, Manal M. Hassan, Jonathan R. Strosberg, Eric P. Krenning, Walter Kocha, Eugene A. Woltering & William J. Maples. (2010) NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors. Pancreas 39:6, pages 784-798.
Crossref
Crossref
J. Philip Boudreaux, David S. Klimstra, Manal M. Hassan, Eugene A. Woltering, Robert T. Jensen, Stanley J. Goldsmith, Charles Nutting, David L. Bushnell, Martyn E. Caplin & James C. Yao. (2010) The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors. Pancreas 39:6, pages 753-766.
Crossref
Crossref
Laurent Zelek & Nicole ZernikAnne Plantade. 2010. Aider á vivre aprés un cancer. Aider á vivre aprés un cancer
51
69
.
Vishal Ghevariya, Anju Malieckal, Nehal Ghevariya, Mohammed Mazumder & Sury Anand. (2009) Carcinoid Tumors of the Gastrointestinal Tract. Southern Medical Journal 102:10, pages 1032-1040.
Crossref
Crossref
Jorge Burgos, Patricia Cobos, Nerea Vidaurrazaga, Begoña Prieto, Iratxe Ocerin & Roberto Matorras. (2009) Ovarian hyperstimulation secondary to ectopic secretion of follicle-stimulating hormone. Literature review prompted by a case. Fertility and Sterility 92:3, pages 1168.e5-1168.e8.
Crossref
Crossref
Klaas P. Koopmans, Oliver N. Neels, Ido P. Kema, Philip H. Elsinga, Thera P. Links, Elisabeth G.E. de Vries & Pieter L. Jager. (2009) Molecular imaging in neuroendocrine tumors: Molecular uptake mechanisms and clinical results. Critical Reviews in Oncology/Hematology 71:3, pages 199-213.
Crossref
Crossref
Janet S. Carpenter, Menggang Yu, Jingwei Wu, Diane Von Ah, Jennifer Milata, Julie L. Otte, Shelley Johns, Bryan Schneider, Anna Maria Storniolo, Ronald Salomon, Zeuresenay Desta, Donghua Cao, Yan Jin, Santosh Philips & Todd C. Skaar. (2009) Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion. Menopause 16:4, pages 644-652.
Crossref
Crossref
Paul A. Sookur, Anju Sahdev, Andrea G. Rockall, Andrea M. Isidori, John P. Monson, Ashley B. Grossman & Rodney H. Reznek. (2009) Imaging in covert ectopic ACTH secretion: a CT pictorial review. European Radiology 19:5, pages 1069-1078.
Crossref
Crossref
David M. Liu, Andrew Kennedy, David Turner, Steven C. Rose, Stephen T. Kee, Samuel Whiting, Ravi Murthy, Charles Nutting, Manraj Heran, Robert Lewandowski, Jesse Knight, Seza Gulec & Riad Salem. (2009) Minimally Invasive Techniques in Management of Hepatic Neuroendocrine Metastatic Disease. American Journal of Clinical Oncology 32:2, pages 200-215.
Crossref
Crossref
John M. LyonsIIIIII, Jeffrey Abergel, Jessica L. Thomson, Cathy T. Anthony, Yi-Zarn Wang, Lowell B. Anthony, J. Philip Boudreaux, James Strauchen, Muhammad Idrees, Richard R. P. Warner & Eugene A. Woltering. (2009) In Vitro Chemoresistance Testing in Well-Differentiated Carcinoid Tumors. Annals of Surgical Oncology 16:3, pages 649-655.
Crossref
Crossref
Karen Albritton, John M. Goldberg & Alberto Pappo. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
989
1013
.
Dara Christante, SuEllen Pommier, Babak Givi & Rodney Pommier. (2008) Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Surgery 144:6, pages 885-894.
Crossref
Crossref
Joy E S Ardill. (2008) Circulating markers for endocrine tumours of the gastroenteropancreatic tract. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 45:6, pages 539-559.
Crossref
Crossref
Manon Buijs, Josephina A. Vossen, Jean-Francois H. Geschwind & Ihab R. Kamel. 2010. Interventional Oncology. Interventional Oncology
86
98
.
James C. Yao, Alexandria T. Phan, David Z. Chang, Robert A. Wolff, Kenneth Hess, Sanjay Gupta, Carmen Jacobs, Jeannette E. Mares, Andrea N. Landgraf, Asif Rashid & Funda Meric-Bernstam. (2008) Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study. Journal of Clinical Oncology 26:26, pages 4311-4318.
Crossref
Crossref
Kotoyo Fujiki, Eva–Maria Duerr, Hirotoshi Kikuchi, Aylwin Ng, Ramnik J. Xavier, Yusuke Mizukami, Takaaki Imamura, Matthew H. Kulke & Daniel C. Chung. (2008) Hoxc6 Is Overexpressed in Gastrointestinal Carcinoids and Interacts With JunD to Regulate Tumor Growth. Gastroenterology 135:3, pages 907-916.e2.
Crossref
Crossref
Manal M. Hassan, Alexandria Phan, Donghui Li, Cecile G. Dagohoy, Colleen Leary & James C. Yao. (2008) Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. International Journal of Cancer 123:4, pages 867-873.
Crossref
Crossref
Mazhar U. Khan & R. Edward Coleman. (2008) Diagnosis and therapy of carcinoid tumors—current state of the art and future directions. Nuclear Medicine and Biology 35, pages S77-S91.
Crossref
Crossref
Ioannis Ilias & Karel Pacak. (2008) A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors. Nuclear Medicine and Biology 35, pages S27-S34.
Crossref
Crossref
James C. Yao, Manal Hassan, Alexandria Phan, Cecile Dagohoy, Colleen Leary, Jeannette E. Mares, Eddie K. Abdalla, Jason B. Fleming, Jean-Nicolas Vauthey, Asif Rashid & Douglas B. Evans. (2008) One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. Journal of Clinical Oncology 26:18, pages 3063-3072.
Crossref
Crossref
Paloma Sánchez-Fayos Calabuig, María Jesús Martín Relloso, Agustina González Guirado & Juan Carlos Porres Cubero. (2008) Tumores carcinoides gastrointestinales. Biología celular, expresión molecular y consecuencias fisiopatológicas de una neoplasia enigmática. Gastroenterología y Hepatología 31:6, pages 356-365.
Crossref
Crossref
F.J. Tbar Mass, I. Lluch Verd, I. Burgas Estall, A.B. Hernndez Cascales, M. Fernndez Lpez & P. Portillo Ortega. (2008) Tumores endocrinos digestivos. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 10:8, pages 499-507.
Crossref
Crossref
James C. Yao, Alexandria Phan, Paulo M. Hoff, Helen X. Chen, Chusilp Charnsangavej, Sai-Ching J. Yeung, Kenneth Hess, Chaan Ng, James L. Abbruzzese & Jaffer A. Ajani. (2008) Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b. Journal of Clinical Oncology 26:8, pages 1316-1323.
Crossref
Crossref
Maria Luisa Brandi, Cesare Bordi, Francesco Tonelli, Alberto Falchetti & Stephen J. Marx. 2008. Principles of Bone Biology. Principles of Bone Biology
1345
1374
.
Kimberly A. Varker, Edward W. Martin, Dori Klemanski, Bryan Palmer, Manisha H. Shah & Mark Bloomston. (2007) Repeat Transarterial Chemoembolization (TACE) for Progressive Hepatic Carcinoid Metastases Provides Results Similar to First TACE. Journal of Gastrointestinal Surgery 11:12, pages 1680-1685.
Crossref
Crossref
Rosario Fornaro, Marco Frascio, Camilla Sticchi, Luigi De Salvo, Cesare Stabilini, Francesca Mandolfino, Barbara Ricci & Ezio Gianetta. (2018) Appendectomy or Right Hemicolectomy in the Treatment of Appendiceal Carcinoid Tumors?. Tumori Journal 93:6, pages 587-590.
Crossref
Crossref
Fadi Braiteh & James Yao. (2007) Electronic Clinical Challenges and Images in GI. Gastroenterology 133:4, pages e1-e2.
Crossref
Crossref
George Van BurenIIII, Asif Rashid, Anthony D. Yang, Eddie K. Abdalla, Michael J. Gray, Wenbiao Liu, Ray Somcio, Fan Fan, E. Ramsay Camp, James C. Yao & Lee M. Ellis. (2007) The Development and Characterization of a Human Midgut Carcinoid Cell Line. Clinical Cancer Research 13:16, pages 4704-4712.
Crossref
Crossref
Catherine G. Jonnakuty & Spyros G.E. Mezitis. (2007) Pulmonary Atypical Carcinoid Tumor with Metastatic Involvement of the Pituitary Gland Causing Functional Hypopituitarism. Endocrine Practice 13:3, pages 291-295.
Crossref
Crossref
Alexander S. HoJoel PicusMichael D. DarcyBenjamin TanJennifer E. GouldThomas K. PilgramDaniel B. Brown. (2007) Long-Term Outcome After Chemoembolization and Embolization of Hepatic Metastatic Lesions from Neuroendocrine Tumors. American Journal of Roentgenology 188:5, pages 1201-1207.
Crossref
Crossref
Wei Hou & Mitchell L. Schubert. (2008) Treatment of gastric carcinoids. Current Treatment Options in Gastroenterology 10:2, pages 123-133.
Crossref
Crossref
Andrew F. Scarsbrook, Arul Ganeshan, Jane Statham, Rajesh V. Thakker, Andrew Weaver, Denis Talbot, Philip Boardman, Kevin M. Bradley, Fergus V. Gleeson & Rachel R. Phillips. (2007) Anatomic and Functional Imaging of Metastatic Carcinoid Tumors. RadioGraphics 27:2, pages 455-477.
Crossref
Crossref
James C. Yao. (2007) Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Practice & Research Clinical Endocrinology & Metabolism 21:1, pages 163-172.
Crossref
Crossref
Lora J. McIntyre & Tamra J. Courey. (2007) Addressing the Physiologic and Psychological Symptoms Associated with Carcinoid Tumors. The Journal for Nurse Practitioners 3:2, pages 110-115.
Crossref
Crossref
Yuqing Yang & Xianxin Hua. (2007) In search of tumor suppressing functions of menin. Molecular and Cellular Endocrinology 265-266, pages 34-41.
Crossref
Crossref
James C. Yao, Jun X. Zhang, Asif Rashid, Sai-Ching J. Yeung, Janio Szklaruk, Kenneth Hess, Keping Xie, Lee Ellis, James L. Abbruzzese & Jaffer A. Ajani. (2007)
Clinical and
In vitro
Studies of Imatinib in Advanced Carcinoid Tumors
. Clinical Cancer Research 13:1, pages 234-240.
Crossref
Crossref
Jennifer A Northrop & Jeffrey H Lee. (2007) Large bowel carcinoid tumors. Current Opinion in Gastroenterology 23:1, pages 74-78.
Crossref
Crossref
. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
1178
1217
.
Kerri M. Robertson. 2007. Complications in Anesthesia. Complications in Anesthesia
814
816
.
Gonzalo Gutierrez, Ian R Daniels, Ana Garcia & Jose M Ramia. (2006) Peritoneal carcinomatosis from a small bowel carcinoid tumour. World Journal of Surgical Oncology 4:1.
Crossref
Crossref
Ian M. Jaffee, Mahdis Rahmani, Maria G. Singhal & Mamoun Younes. (2006) Expression of the Intestinal Transcription Factor CDX2 in Carcinoid Tumors Is a Marker of Midgut Origin. Archives of Pathology & Laboratory Medicine 130:10, pages 1522-1526.
Crossref
Crossref
Joseph Klink, Harry Rutland, Lara Harik & Kenneth Ogan. (2006) Primary carcinoid tumor in an ileal conduit. Urology 68:3, pages 672.e9-672.e10.
Crossref
Crossref
David C. Madoff, Sanjay Gupta, Kamran Ahrar, Ravi Murthy & James C. Yao. (2006) Update on the Management of Neuroendocrine Hepatic Metastases. Journal of Vascular and Interventional Radiology 17:8, pages 1235-1250.
Crossref
Crossref
Irvin M. Modlin, Igor Latich, Michelle Zikusoka, Mark Kidd, Geeta Eick & Anthony K. C. Chan. (2006) Gastrointestinal Carcinoids: The Evolution of Diagnostic Strategies. Journal of Clinical Gastroenterology 40:7, pages 572-582.
Crossref
Crossref
Irvin M. Modlin, Mark Kidd, Igor Latich, Michelle N. Zikusoka, Geeta N. Eick, Shrikant M. Mane & Robert L. Camp. (2006) Genetic Differentiation of Appendiceal Tumor Malignancy. Annals of Surgery 244:1, pages 52-60.
Crossref
Crossref
Annelies H. Boekhout, Jos H. Beijnen & Jan H.M. Schellens. (2006) Symptoms and Treatment in Cancer Therapy-Induced Early Menopause. The Oncologist 11:6, pages 641-654.
Crossref
Crossref
Chandrajit P. Raut, Matthew H. Kulke, Jonathan N. Glickman, Richard S. Swanson & Stanley W. Ashley. (2006) Carcinoid Tumors. Current Problems in Surgery 43:6, pages 391-450.
Crossref
Crossref
Irvin M. Modlin, Igor Latich, Mark Kidd, Michelle Zikusoka & Geeta Eick. (2006) Therapeutic Options for Gastrointestinal Carcinoids. Clinical Gastroenterology and Hepatology 4:5, pages 526-547.
Crossref
Crossref
M. Donadon, G. Torzilli, A. Palmisano, D. Del Fabbro, V. Panizzo, M. Maggioni, R. Santambrogio & M. Montorsi. (2006) Liver resection for primary hepatic neuroendocrine tumours: Report of three cases and review of the literature. European Journal of Surgical Oncology (EJSO) 32:3, pages 325-328.
Crossref
Crossref
Jui-Sheng Hsu, Wan-Yi Kang, Shah-Hwa Chou & Ming-Tsung Chuang. (2006) Mature Cystic Teratoma in the Anterior Mediastinum Containing a Carcinoid. Journal of Thoracic Imaging 21:1, pages 60-62.
Crossref
Crossref
Mark Kidd, Irvin M. Modlin, Shrikant M. Mane, Robert L. Camp, Geeta Eick & Igor Latich. (2006) The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia. Annals of Surgical Oncology 13:2, pages 253-262.
Crossref
Crossref
Neal S. Goldstein & David S. Bosler. 2006. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry
442
508
.
Willscott E. Naugler & Gordon C. Hunt. 2006. Endoscopic Oncology. Endoscopic Oncology
161
172
.
Sanjay Gupta, Marcella M. Johnson, Ravi Murthy, Kamran Ahrar, Michael J. Wallace, David C. Madoff, Stephen E. McRae, Marshall E. Hicks, Sujaya Rao, Jean‐Nicolas Vauthey, Jaffer A. Ajani & James C. Yao. (2005) Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors. Cancer 104:8, pages 1590-1602.
Crossref
Crossref
Mark D. Williams & Tamara J. Dolenc. (2005) Selective Serotonin Reuptake Inhibitors and Patients With Carcinoid Tumor. Psychosomatics 46:4, pages 370-372.
Crossref
Crossref
Richard M. Gore, Jonathan W. Berlin, Uday K. Mehta, Geraldine M. Newmark & Vahid Yaghmai. (2005) GI carcinoid tumours: appearance of the primary and detecting metastases. Best Practice & Research Clinical Endocrinology & Metabolism 19:2, pages 245-263.
Crossref
Crossref
Irvin M. Modlin, Mark Kidd, Igor Latich, Michelle N. Zikusoka & Michael D. Shapiro. (2005) Current Status of Gastrointestinal Carcinoids. Gastroenterology 128:6, pages 1717-1751.
Crossref
Crossref
R. Kianmanesh, D. O’Toole, A. Sauvanet, P. Ruszniewski & J. Belghiti. (2005) Traitement chirurgical des tumeurs endocrines gastro-entéro-pancréatiques. Journal de Chirurgie 142:3, pages 132-149.
Crossref
Crossref
Janet S. Carpenter. (2005) State of the Science: Hot Flashes and Cancer, Part 1: Definition, Scope, Impact, Physiology, and Measurement. Oncology Nursing Forum 32:5, pages 959-968.
Crossref
Crossref
Irvin M. Modlin, Michael D. Shapiro & Mark Kidd. (2004) Siegfried oberndorfer: Origins and perspectives of carcinoid tumors. Human Pathology 35:12, pages 1440-1451.
Crossref
Crossref
Kenneth J. Woodside, Courtney M. TownsendJr.Jr. & B.Mark Evers. (2004) Current management of gastrointestinal carcinoid tumors. Journal of Gastrointestinal Surgery 8:6, pages 742-756.
Crossref
Crossref
Ralph W. Moss. (2016) Cancer and Complementary and Alternative Medicine in Italy: Personal Observations and Historical Considerations. Integrative Cancer Therapies 3:2, pages 173-188.
Crossref
Crossref